Toll Free: 855.9VSTOCK

Client Logins

      Issuer Login

      Shareholder Login

      Proxy Voting Login





Dipexium Pharmaceuticals Inc. announces the closing of its initial public offering of about 3.16 million shares of its common stock at a public offering price of $12.00 per share

Ruthigen Inc Announces Initial Public Offering-Form S-1/A


Liver disease biotech Galmed files for a $35 million IPO



Cancer diagnostics and therapeutics company Microlin Bio files for

a $25 million IPO

Tonix Pharmaceuticals


Announces Closing of Public Offering

Heat Bio's (NASDAQ: HTBX)

IPO haul stands at $26M following over allotment

China Commercial Credit

 (NASDAQ: CCCR) Prices Initial Public Offering; Begins Trading

Organovo Holdings


Closes $46.6 Million Public Offering of Common Stock

Matinas BioPharma Inc. is a privately-held biopharmaceutical company

Intercept Pharmaceuticals

Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares

©2013 All Rights Reserved Vstock Transfer, LLC     Disclaimer

Design by GraphicIQ